Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models
出版年份 2018 全文链接
标题
Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-01-25
DOI
10.3389/fphar.2018.00020
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- How to develop a more accurate risk prediction model when there are few events
- (2015) Menelaos Pavlou et al. BMJ-British Medical Journal
- How to develop a more accurate risk prediction model when there are few events
- (2015) Menelaos Pavlou et al. BMJ-British Medical Journal
- Three decades of low-dose methotrexate in rheumatoid arthritis: Can we predict toxicity?
- (2014) Vasco C. Romão et al. IMMUNOLOGIC RESEARCH
- Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation
- (2014) Sabyasachi Senapati et al. Pharmacogenetics and Genomics
- Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers
- (2014) Aurea Lima et al. PHARMACOGENOMICS
- Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update
- (2014) Hong Zhu et al. PHARMACOGENOMICS
- Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients
- (2014) Aurea Lima et al. PLoS One
- SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms as Predictors of Methotrexate-Related Toxicity in Portuguese Rheumatoid Arthritis Patients
- (2014) Aurea Lima et al. TOXICOLOGICAL SCIENCES
- Prediction of Methotrexate Clinical Response in Portuguese Rheumatoid Arthritis Patients: Implication ofMTHFRrs1801133 andATICrs4673993 Polymorphisms
- (2014) Aurea Lima et al. Biomed Research International
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?
- (2013) Vasco Crispim Romão et al. BMC Medicine
- International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms
- (2013) K M Giacomini et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Methotrexate pharmacogenetics in rheumatoid arthritis: a status report
- (2013) Fardina Malik et al. PHARMACOGENOMICS
- Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine
- (2013) Maša Umićević Mirkov et al. PHARMACOGENOMICS
- Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid arthritis: results from the treatment of early aggressive rheumatoid arthritis trial
- (2013) S Aslibekyan et al. PHARMACOGENOMICS JOURNAL
- RFC180G>A Is a Genetic Determinant of Methotrexate Efficacy in Rheumatoid Arthritis: A Human Genome Epidemiologic Review and Meta-Analysis of Observational Studies
- (2013) Tabitha N. Kung et al. Arthritis & Rheumatology
- Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
- (2012) Maja Bulatović et al. ANNALS OF THE RHEUMATIC DISEASES
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients
- (2012) Biljana Jekic et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Annotation of functional variation in personal genomes using RegulomeDB
- (2012) A. P. Boyle et al. GENOME RESEARCH
- Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients
- (2012) Petra Bohanec Grabar et al. PHARMACOGENOMICS
- Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure
- (2012) Jaap Fransen et al. PHARMACOGENOMICS
- Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients
- (2012) S A Owen et al. PHARMACOGENOMICS JOURNAL
- Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
- (2011) L. B. Ramsey et al. GENOME RESEARCH
- PharmGKB summary
- (2011) Torben S. Mikkelsen et al. Pharmacogenetics and Genomics
- A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release
- (2011) Katia Varani et al. ARTHRITIS RESEARCH & THERAPY
- Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway
- (2010) P. B. Grabar et al. ANNALS OF THE RHEUMATIC DISEASES
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- L1Penalized Estimation in the Cox Proportional Hazards Model
- (2009) Jelle J. Goeman BIOMETRICAL JOURNAL
- SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies
- (2009) Zongli Xu et al. NUCLEIC ACIDS RESEARCH
- Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians
- (2009) Shruti Sharma et al. Pharmacogenetics and Genomics
- The Disease Activity Score and the EULAR Response Criteria
- (2009) Jaap Fransen et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism
- (2008) Petra Bohanec Grabar et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX
- (2008) S. L. Hider et al. RHEUMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now